<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>207940 on Korea Invest Insights</title><link>https://koreainvestinsights.com/tags/207940/</link><description>Recent content in 207940 on Korea Invest Insights</description><generator>Hugo -- gohugo.io</generator><language>en</language><copyright>koreainvestinsights.com · @korea_invest_insights</copyright><lastBuildDate>Mon, 09 Nov 2026 00:12:47 +0900</lastBuildDate><atom:link href="https://koreainvestinsights.com/tags/207940/feed.xml" rel="self" type="application/rss+xml"/><item><title>If Samsung Electronics Stalls Near ₩200,000, Large-Cap Biotech Is Korea's Best-Placed Leader. Pension Funds Are Already Buying It</title><link>https://koreainvestinsights.com/post/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/</link><pubDate>Mon, 09 Nov 2026 00:11:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/</guid><description>&lt;img src="https://koreainvestinsights.com/" alt="Featured image of post If Samsung Electronics Stalls Near ₩200,000, Large-Cap Biotech Is Korea's Best-Placed Leader. Pension Funds Are Already Buying It" /&gt;&lt;p&gt;Samsung Electronics closed at ₩188,700 on November 6, &lt;strong&gt;47.9% below&lt;/strong&gt; its June 18 peak of ₩362,500. The KOSPI closed at 5,060, &lt;strong&gt;44.5% below&lt;/strong&gt; its June 22 closing peak. Only 14.5% of stocks traded above their 50-day average, and our market-regime report reads Bear.&lt;/p&gt;
&lt;p&gt;A rebound to ₩200,000–215,000 would be a gain of 6% to 14%. What matters for the rest of the market comes after that. If Samsung stalls there instead of rallying, which group of stocks takes the lead?&lt;/p&gt;
&lt;p&gt;We tested four candidates with equal-weighted baskets built from KRX data: large-cap biotech and pharma, data centers (Naver, SK Telecom and other telecom and platform names), shipbuilding, defense and nuclear, and batteries. For each basket we measured how it reacts when Samsung makes a big move and where domestic and foreign money went over the last 20 trading days.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Our view: if Samsung stalls near ₩200,000, large-cap biotech and pharma is the likeliest leader. Data centers come second, shipbuilding, defense and nuclear third, and batteries last. A fifth outcome stays live: none of the four qualifies, and domestic-demand stocks such as airlines keep the top relative strength. &amp;ldquo;Leader&amp;rdquo; here means beating the KOSPI. It does not mean rising in absolute terms, and the typical biotech stock is still 56% below its yearly high.&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;On the 14 days in the last 40 trading days when Samsung fell 2% or more, the biotech basket fell 1.89% on average. Batteries fell 3.82%, defense 3.44%, nuclear 3.22% and shipbuilding 3.01%. On the 9 days Samsung rose 2% or more, biotech gained 1.38%, the most of the six baskets.&lt;/li&gt;
&lt;li&gt;Over the 20 trading days from October 12 to November 6, pension funds bought an estimated ₩871 billion of biotech and sold shipbuilding (₩103 billion), defense (₩168 billion) and nuclear (₩201 billion). Foreign investors sold ₩1.39 trillion of batteries.&lt;/li&gt;
&lt;li&gt;Data-center stocks rose 10.0% in five days, but they barely follow Samsung (correlation 0.06) and make up only 1.56% of market trading value. We read that as a shelter, not a leader, until Naver reports on November 12.&lt;/li&gt;
&lt;li&gt;The lead is limited to KOSPI large caps. Since October 28, Hanmi Pharm rose 26.4%, SK Biopharmaceuticals 18.1%, Celltrion 11.2% and Samsung Biologics 10.5%, while Alteogen, LigaChem Biosciences and ABL Bio fell 10% to 14%.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;img alt="Our order if Samsung Electronics stalls near 200,000 won. One: large-cap biotech and pharma, because pension funds bought 871 billion won in 20 trading days and the basket fell 1.89% on Samsung’s big down days. Two: data centers, up 10.0% in five days but with a correlation of 0.06 to Samsung, which reads as a shelter. Three: shipbuilding, defense and nuclear, where shipbuilding is best, nuclear is weakest and pension funds sold all three. Four: batteries, with 1.39 trillion won of foreign selling and a 3.82% fall on Samsung’s big down days. A fifth outcome stays live: none of the four qualifies, and only airlines held confirmed leadership in the November 6 five-day scan." loading="lazy" sizes="(max-width: 767px) calc(100vw - 30px), (max-width: 1023px) 700px, (max-width: 1279px) 950px, 1232px" src="https://koreainvestinsights.com/post-assets/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/ladder.en.svg"&gt;
&lt;/p&gt;
&lt;p&gt;This post follows our note on what Samsung&amp;rsquo;s ₩188,700 already prices in, &lt;a class="link" href="https://koreainvestinsights.com/post/samsung-188700-prices-three-bear-cases-at-once-2026-11-08/" &gt;Samsung at ₩188,700 Only Works If Three Bear Cases Hit at Once&lt;/a&gt;. The wider foreign-flow map is in the &lt;a class="link" href="https://koreainvestinsights.com/page/korea-stocks-foreign-investors-hub/" &gt;Korea stocks for foreign investors hub&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id="who-buys-while-samsung-stalls-decides-which-group-leads"&gt;Who buys while Samsung stalls decides which group leads
&lt;/h2&gt;&lt;p&gt;If Samsung stalls, foreign selling of the chip giants can pause. Foreign investors sold ₩16.6 trillion of Samsung Electronics and SK hynix over the last 20 trading days. But the won weakened from 1,325 per dollar on November 2 to 1,356 on November 6, so broad foreign buying of Korean stocks is hard to count on.&lt;/p&gt;
&lt;p&gt;That leaves domestic institutions, and pension funds in particular, to set the direction of the rotation. Pension funds put an estimated ₩871 billion into biotech and pharma over the 20 trading days and took money out of all three of shipbuilding, defense and nuclear. Celltrion (₩302 billion) and Samsung Biologics (₩414 billion) account for about 82% of the biotech total.&lt;/p&gt;
&lt;p&gt;&lt;img alt="Pension funds bought 870.7 billion won of biotech and pharma in 20 trading days to November 6 and sold 103.0 billion won of shipbuilding, 167.6 billion of defense and 201.1 billion of nuclear. They bought 412.3 billion won of batteries and 161.0 billion of data centers. Foreign investors sold 1,387.8 billion won of batteries and 115.9 billion of biotech, and bought small amounts of data centers, shipbuilding, defense and nuclear." loading="lazy" sizes="(max-width: 767px) calc(100vw - 30px), (max-width: 1023px) 700px, (max-width: 1279px) 950px, 1232px" src="https://koreainvestinsights.com/post-assets/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/flows.en.svg"&gt;
&lt;/p&gt;
&lt;p&gt;We treat this as the heaviest variable. A group that domestic pension money keeps buying can hold up when nobody else is buying. Foreign investors went the other way on batteries, selling ₩1.39 trillion, the largest outflow among the six baskets.&lt;/p&gt;
&lt;h2 id="biotech-keeps-pace-when-samsung-rises-and-gives-back-less-when-it-falls"&gt;Biotech keeps pace when Samsung rises and gives back less when it falls
&lt;/h2&gt;&lt;p&gt;Pension buying shows who is willing to hold biotech. The reaction to Samsung&amp;rsquo;s big days shows how biotech behaves in either direction. In the last 40 trading days, Samsung fell 2% or more on 14 days and rose 2% or more on 9 days.&lt;/p&gt;
&lt;p&gt;On the down days the biotech basket lost 1.89% on average, against 3.01% for shipbuilding, 3.22% for nuclear, 3.44% for defense and 3.82% for batteries. On the up days biotech gained 1.38%, the most of the six baskets.&lt;/p&gt;
&lt;p&gt;&lt;img alt="On the 9 days Samsung rose 2% or more, biotech averaged +1.38%, the most of six baskets. On the 14 days Samsung fell 2% or more, biotech averaged -1.89%, against -3.01% for shipbuilding, -3.22% for nuclear, -3.44% for defense and -3.82% for batteries. Data centers moved +0.05% and -0.34% but barely track Samsung, with a correlation of 0.06." loading="lazy" sizes="(max-width: 767px) calc(100vw - 30px), (max-width: 1023px) 700px, (max-width: 1279px) 950px, 1232px" src="https://koreainvestinsights.com/post-assets/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/reaction.en.svg"&gt;
&lt;/p&gt;
&lt;p&gt;Shipbuilding (−0.42%) and nuclear (−0.18%) did not rise on Samsung&amp;rsquo;s big up days, and both fell about 3% on its down days. That looks like a separate de-rating, not a rotation waiting for its turn. Batteries have the weakest down-day number and the heaviest foreign selling.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Basket&lt;/th&gt;
 &lt;th&gt;Last 5 days&lt;/th&gt;
 &lt;th&gt;Since Oct 28&lt;/th&gt;
 &lt;th&gt;Samsung up days&lt;/th&gt;
 &lt;th&gt;Samsung down days&lt;/th&gt;
 &lt;th&gt;Pension funds, 20 days (₩B)&lt;/th&gt;
 &lt;th&gt;Foreign investors, 20 days (₩B)&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;Biotech and pharma&lt;/td&gt;
 &lt;td&gt;+0.1%&lt;/td&gt;
 &lt;td&gt;−6.0%&lt;/td&gt;
 &lt;td&gt;+1.38%&lt;/td&gt;
 &lt;td&gt;−1.89%&lt;/td&gt;
 &lt;td&gt;+870.7&lt;/td&gt;
 &lt;td&gt;−115.9&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Data centers&lt;/td&gt;
 &lt;td&gt;+10.0%&lt;/td&gt;
 &lt;td&gt;+7.6%&lt;/td&gt;
 &lt;td&gt;+0.05%&lt;/td&gt;
 &lt;td&gt;−0.34%&lt;/td&gt;
 &lt;td&gt;+161.0&lt;/td&gt;
 &lt;td&gt;+115.5&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Shipbuilding&lt;/td&gt;
 &lt;td&gt;−4.7%&lt;/td&gt;
 &lt;td&gt;−8.9%&lt;/td&gt;
 &lt;td&gt;−0.42%&lt;/td&gt;
 &lt;td&gt;−3.01%&lt;/td&gt;
 &lt;td&gt;−103.0&lt;/td&gt;
 &lt;td&gt;+161.0&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Defense&lt;/td&gt;
 &lt;td&gt;−6.5%&lt;/td&gt;
 &lt;td&gt;−16.1%&lt;/td&gt;
 &lt;td&gt;+0.84%&lt;/td&gt;
 &lt;td&gt;−3.44%&lt;/td&gt;
 &lt;td&gt;−167.6&lt;/td&gt;
 &lt;td&gt;+189.4&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Nuclear&lt;/td&gt;
 &lt;td&gt;−10.5%&lt;/td&gt;
 &lt;td&gt;−19.9%&lt;/td&gt;
 &lt;td&gt;−0.18%&lt;/td&gt;
 &lt;td&gt;−3.22%&lt;/td&gt;
 &lt;td&gt;−201.1&lt;/td&gt;
 &lt;td&gt;+131.5&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Batteries&lt;/td&gt;
 &lt;td&gt;−8.0%&lt;/td&gt;
 &lt;td&gt;−13.5%&lt;/td&gt;
 &lt;td&gt;+0.41%&lt;/td&gt;
 &lt;td&gt;−3.82%&lt;/td&gt;
 &lt;td&gt;+412.3&lt;/td&gt;
 &lt;td&gt;−1,387.8&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;For reference: Samsung and SK hynix&lt;/td&gt;
 &lt;td&gt;−18.2%&lt;/td&gt;
 &lt;td&gt;−22.9%&lt;/td&gt;
 &lt;td&gt;+4.23%&lt;/td&gt;
 &lt;td&gt;−5.35%&lt;/td&gt;
 &lt;td&gt;+985.0&lt;/td&gt;
 &lt;td&gt;−16,611.0&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;Read the table by rows. Only biotech combines pension buying with a mild reaction on Samsung&amp;rsquo;s down days. Data centers are the only basket that rose over the last five days and since October 28, but they barely follow Samsung.&lt;/p&gt;
&lt;h2 id="biotechs-lead-stops-at-the-kospi-large-caps"&gt;Biotech&amp;rsquo;s lead stops at the KOSPI large caps
&lt;/h2&gt;&lt;p&gt;&lt;img alt="Since October 28, KOSPI large caps rose: Hanmi Pharm 26.4%, SK Biopharmaceuticals 18.1%, Celltrion 11.2% and Samsung Biologics 10.5%. KOSDAQ platform biotechs fell: Alteogen 10.1%, LigaChem Biosciences 11.8% and ABL Bio 13.8%. Regular-session closing prices, October 28 to November 6, 2026." loading="lazy" sizes="(max-width: 767px) calc(100vw - 30px), (max-width: 1023px) 700px, (max-width: 1279px) 950px, 1232px" src="https://koreainvestinsights.com/post-assets/samsung-stalls-near-200k-large-cap-biotech-leads-pension-funds-2026-11-09/stocks.en.svg"&gt;
&lt;/p&gt;
&lt;p&gt;The biotech basket&amp;rsquo;s median hides a split. Large KOSPI names carry the pension buying and the gains. The KOSDAQ platform companies fell over the same period. For the lead to spread to them, US yields would have to keep falling. The 10-year Treasury yield was 4.84% on November 5, down from 5.27% on October 6.&lt;/p&gt;
&lt;p&gt;In the first stretch of any Samsung rebound, the most heavily sold names can bounce hardest. A bounce is not leadership, and the scoring rule later in this post keeps the two apart.&lt;/p&gt;
&lt;p&gt;We also share new analyses on Telegram as they are published. You are welcome to join us at &lt;a class="link" href="https://t.me/korea_invest_insights" target="_blank" rel="noopener"
 &gt;@korea_invest_insights&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id="data-centers-look-like-a-shelter-until-naver-reports"&gt;Data centers look like a shelter until Naver reports
&lt;/h2&gt;&lt;p&gt;The data-center basket (Naver, SK Telecom, KT, LG Uplus, Samsung SDS and Kakao) rose 10.0% in five days and 7.6% since October 28, the only basket that is up. Its correlation with Samsung is 0.06, and it fell only 0.34% on Samsung&amp;rsquo;s big down days. Those are the numbers of a low-beta defensive group. We read the rally as shelter demand during a selloff, and that demand can unwind when Samsung rebounds.&lt;/p&gt;
&lt;p&gt;A story could turn the shelter into a leader. After the November 3 midterms, Democrat Gina Hinojosa won the Texas governor&amp;rsquo;s race. She had pledged to halt approvals of new data centers until laws on grid load, water use and electricity bills are in place (ZDNet Korea, November 5). She takes office in January, so for now it is a pledge, not a halt. NH Investment &amp;amp; Securities named SK Telecom, KT and LG Uplus as likely beneficiaries if Big Tech builds data centers outside the US (Newsprime, November 8). On November 6, Hana Securities called the regulation fear overdone for Samsung and SK hynix (Hankyung).&lt;/p&gt;
&lt;p&gt;All three items are press reports. We have not read the underlying research, and no one has shown how much of this would reach Naver&amp;rsquo;s or SK Telecom&amp;rsquo;s revenue. The basket also makes up only 1.56% of market trading value, against 2.69% for biotech. That is too small to carry an index.&lt;/p&gt;
&lt;p&gt;Naver reports third-quarter results at 09:00 on November 12, according to its disclosure. If AI-infrastructure revenue and the investment plan hold up, data centers move to first.&lt;/p&gt;
&lt;h2 id="among-shipbuilding-defense-and-nuclear-shipbuilding-is-strongest-and-nuclear-weakest"&gt;Among shipbuilding, defense and nuclear, shipbuilding is strongest and nuclear weakest
&lt;/h2&gt;&lt;p&gt;All three baskets are 60% to 68% below their yearly highs, and they have different problems. For nuclear, Korea Hydro &amp;amp; Nuclear Power (KHNP) ended construction-contract talks with the Daewoo E&amp;amp;C and Doosan Enerbility consortium for the Czech Dukovany plant on October 29. KHNP said Daewoo E&amp;amp;C&amp;rsquo;s extra cost demand passed ₩1 trillion after KHNP had offered a 10% increase in the construction price (Seoul Shinmun). Doosan Enerbility said it will join the rebidding. Its separate reactor and turbine supply contract continues.&lt;/p&gt;
&lt;p&gt;The nuclear basket is down 19.9% since October 28. We did not measure how much of that the Dukovany news explains. Over 20 trading days every investor group sold Doosan Enerbility: foreign investors ₩125 billion, institutions ₩148 billion and pension funds ₩113 billion.&lt;/p&gt;
&lt;p&gt;If the Texas pledge turns into policy, it would also cut the AI power-demand story that lifted nuclear and power equipment, and it would weaken the energy-storage demand story for batteries. Shipbuilding sits farther from that path. Institutions bought ₩466 billion of Hanwha Ocean over the 20 days, although pension funds sold ₩56 billion. In our November 6 five-day sector scan, KOSPI shipbuilding ranked fourth on rebound-day alpha (+3.81), but analysts&amp;rsquo; sector target prices were cut 28.8% over four weeks.&lt;/p&gt;
&lt;h2 id="what-would-change-the-order"&gt;What would change the order
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Outcome&lt;/th&gt;
 &lt;th&gt;What would raise it&lt;/th&gt;
 &lt;th&gt;What would lower it&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;Large-cap biotech and pharma&lt;/td&gt;
 &lt;td&gt;Pension funds keep buying Celltrion and Samsung Biologics&lt;/td&gt;
 &lt;td&gt;The US 10-year yield rises back above 5.0%, or the five-day pension total for Celltrion and Samsung Biologics turns negative&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Data centers&lt;/td&gt;
 &lt;td&gt;Gains hold on Samsung&amp;rsquo;s rebound days, and Naver&amp;rsquo;s November 12 results confirm AI-infrastructure revenue and investment plans. Then data centers move to first&lt;/td&gt;
 &lt;td&gt;Gains are given back quickly as Samsung rebounds&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Shipbuilding, defense and nuclear (shipbuilding first)&lt;/td&gt;
 &lt;td&gt;Sector target-price cuts stop, and the reaction on Samsung up days turns positive&lt;/td&gt;
 &lt;td&gt;Pension selling continues and nuclear stays the weakest&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Batteries&lt;/td&gt;
 &lt;td&gt;Foreign investors turn from net sellers to net buyers over 20 days&lt;/td&gt;
 &lt;td&gt;Stays last until then&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;None of the four qualifies&lt;/td&gt;
 &lt;td&gt;Domestic-demand stocks such as airlines, retail and food keep the top relative strength&lt;/td&gt;
 &lt;td&gt;Any of the four meets the scoring bar below&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id="how-we-will-score-it"&gt;How we will score it
&lt;/h2&gt;&lt;p&gt;We fixed the rules before the result. The start day is the first day on which Samsung has closed between ₩200,000 and ₩215,000 for 10 trading days in a row. Over the next 20 trading days, a basket counts as the leader only if it meets all three conditions.&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Its equal-weighted median return beats the KOSPI by 5 percentage points or more.&lt;/li&gt;
&lt;li&gt;Foreign and institutional investors together are net buyers of it.&lt;/li&gt;
&lt;li&gt;Its average share of market trading value over the 20 days is higher than over the previous 60 days.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;If two or more baskets qualify, the one with the larger excess return in condition 1 wins. If Samsung falls below ₩180,000 before the start day, the premise is broken and we do not score. If it stays above ₩220,000 for more than ten trading days, we treat that as a new rally and do not score either.&lt;/p&gt;
&lt;h2 id="what-to-check-next"&gt;What to check next
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Date&lt;/th&gt;
 &lt;th&gt;What to check&lt;/th&gt;
 &lt;th&gt;Effect on the order&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;November 9 to 13&lt;/td&gt;
 &lt;td&gt;How much data-center stocks give back on days Samsung rebounds&lt;/td&gt;
 &lt;td&gt;A small giveback supports moving data centers up&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;November 12&lt;/td&gt;
 &lt;td&gt;Naver&amp;rsquo;s third-quarter results at 09:00: AI-infrastructure revenue and investment plans. Monthly KOSPI 200 options expire the same day&lt;/td&gt;
 &lt;td&gt;Data centers move up or stay&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Every day&lt;/td&gt;
 &lt;td&gt;Five-day pension total for Celltrion and Samsung Biologics&lt;/td&gt;
 &lt;td&gt;A negative total moves biotech down&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Every day&lt;/td&gt;
 &lt;td&gt;US 10-year yield against 5.0%&lt;/td&gt;
 &lt;td&gt;A move above 5.0% moves biotech down&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;From the start day&lt;/td&gt;
 &lt;td&gt;The 20-trading-day scoring rule above&lt;/td&gt;
 &lt;td&gt;Decides the leader&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id="data-notes"&gt;Data notes
&lt;/h2&gt;&lt;ul&gt;
&lt;li&gt;The baskets are our own choice, and equal-weighted medians change when constituents change. Biotech and pharma, 17 stocks: Samsung Biologics, Celltrion, Alteogen, Yuhan, LigaChem Biosciences, ABL Bio, HLB, Sam Chun Dang Pharm, Peptron, Hanmi Pharm, SK Biopharmaceuticals, PharmaResearch, Voronoi, Hugel, ST Pharm, D&amp;amp;D Pharmatech and Kolon TissueGene. Batteries, 12 stocks: LG Energy Solution, Samsung SDI, EcoPro BM, EcoPro, POSCO Future M, L&amp;amp;F, POSCO Holdings, LG Chem, SK Innovation, Enchem, EcoPro Materials and Lotte Energy Materials. Data centers, 6 stocks: Naver, SK Telecom, KT, LG Uplus, Samsung SDS and Kakao. Shipbuilding (6), defense (5) and nuclear (6) follow the same rule.&lt;/li&gt;
&lt;li&gt;Samsung-day reactions are the average of each basket&amp;rsquo;s daily median return on the 14 days in the last 40 trading days when Samsung fell 2% or more and the 9 days it rose 2% or more. Those samples are small.&lt;/li&gt;
&lt;li&gt;Net buying by investor type is an estimate in won from KRX data in our database, summed over the 20 trading days from October 12 to November 6.&lt;/li&gt;
&lt;li&gt;Prices are KRX regular-session closes on November 6. Some portals show a later price that includes extended-session trading: Samsung Electronics closed at ₩188,700 in the regular session, while Naver&amp;rsquo;s daily price list shows ₩193,500.&lt;/li&gt;
&lt;li&gt;KOSPI closed at 5,059.69 on November 6. Its closing peak was 9,114.55 on June 22, and the intraday high was 9,385.59 on June 19. USD/KRW was 1,325.5 on November 2 and 1,356.3 on November 6. The US 10-year yield is the November 5 value from FRED.&lt;/li&gt;
&lt;li&gt;The Bear regime and the 14.5% share of stocks above their 50-day average come from our own macro-regime report of November 8, which uses November 6 data. The five-day sector scan is our own November 6 scan.&lt;/li&gt;
&lt;li&gt;The Texas pledge, the NH Investment &amp;amp; Securities and Hana Securities comments, the Dukovany talks and the Naver date come from press reports. We did not read the brokers&amp;rsquo; research or KHNP&amp;rsquo;s own statement. The monthly KOSPI 200 options expiry follows the usual second-Thursday rule, and we did not check it against a KRX notice.&lt;/li&gt;
&lt;li&gt;We did not check why shipbuilding, defense and nuclear fell more than 60% from their highs. The Dukovany news explains part of nuclear at most.&lt;/li&gt;
&lt;li&gt;Prices for the seven stocks in the third chart, and for Samsung Electronics, come from Yahoo Finance regular-session closes.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Sources:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a class="link" href="https://finance.yahoo.com/quote/%5EKS11/" target="_blank" rel="noopener"
 &gt;Yahoo Finance, KOSPI index&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://finance.yahoo.com/quote/KRW%3DX/" target="_blank" rel="noopener"
 &gt;Yahoo Finance, USD/KRW&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://finance.yahoo.com/quote/005930.KS/" target="_blank" rel="noopener"
 &gt;Yahoo Finance, Samsung Electronics (005930.KS)&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://fred.stlouisfed.org/series/DGS10" target="_blank" rel="noopener"
 &gt;FRED, 10-year Treasury yield&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://zdnet.co.kr/view/?no=20261105093759" target="_blank" rel="noopener"
 &gt;ZDNet Korea on the Texas data-center pledge&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://www.newsprime.co.kr/news/article/?no=754050" target="_blank" rel="noopener"
 &gt;Newsprime on NH Investment &amp;amp; Securities and data centers&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://www.hankyung.com/article/2026110697926" target="_blank" rel="noopener"
 &gt;Hankyung on Hana Securities and the regulation fear&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://m.seoul.co.kr/news/newsView.php?id=20261030029003" target="_blank" rel="noopener"
 &gt;Seoul Shinmun on the Dukovany talks&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a class="link" href="https://www.vegannews.co.kr/news/article.html?no=394829" target="_blank" rel="noopener"
 &gt;Vegan News on Naver&amp;rsquo;s third-quarter results date&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Two questions for the comments.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;1. If Samsung stalls near ₩200,000, which group do you expect to lead? A. Large-cap biotech and pharma. B. Data centers. C. Shipbuilding, defense and nuclear. D. Batteries. E. None of them.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2. Which signal would change your mind first? A. The US 10-year yield above 5.0%. B. Pension funds stop buying Celltrion and Samsung Biologics. C. Naver&amp;rsquo;s AI-infrastructure numbers on November 12. D. Samsung falling below ₩180,000.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;This is for research and information only, not investment advice. Estimates, multiples and triggers are analytical assumptions, not trading instructions or individual portfolio decisions. Figures are dated data. We used Anthropic&amp;rsquo;s Claude to help collect sources and edit this post. Anthropic is one of the users of data-center capacity, so it is a demand source behind one of the four groups discussed here. We do not judge how large that effect is.&lt;/p&gt;</description></item></channel></rss>